Increased frequency of circulating Tc22/Th22 cells and polyfunctional CD38- T cells in HIV-exposed uninfected subjects

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Oliveira, Luanda M S ^a   Lima, Josenilson F ^a   Cervantes, Cesar A C ^a   Casseb, Jorge S ^a   Mendoncą, Marcelo ^b   Duarte, Alberto J S ^a   Sato, Maria N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Emilio Ribas Infectious Diseases Institute   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CYTOKINE; GAG PROTEIN;

ADULT; BIOSYNTHESIS; BLOOD; CD4 LYMPHOCYTE COUNT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD38; CD4 LYMPHOCYTE COUNT; CYTOKINES; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTE SUBSETS;

EID: 84941058531     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13883     Document Type: Article

References (31)

1. UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. (2013), Avaliable at: http://www.unaids.org/sites/default/files/media-asset/UNAIDS-Global-Report-2013-en-1.pdf (Accessed: 16th September 2014).
2. Horton, R. E., McLaren, P. J., Fowke, K., Kimani, J., Ball, T. B. Cohorts for the study of HIV1-exposed but uninfected individuals: benefits and limitations. J Infect Dis 202 Suppl 3, S377-381, doi: 10.1086/655971 (2010).
3. Shearer, G., Clerici, M. Historical perspective on HIVexposed seronegative individuals: has nature done the experiment for us J Infect Dis 202 Suppl 3, S329-332, doi: 10.1086/655974 (2010).
4. Pancino, G., Saez-Cirion, A., Scott-Algara, D., Paul, P. Natural resistance to HIV infection: lessons learned from HIVexposed uninfected individuals. J Infect Dis 202 Suppl 3, S345-350, doi: 10.1086/655973 (2010).
5. Liu, R. et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996).
6. Lederman, M. M. et al. Determinants of protection among HIVexposed seronegative persons: an overview. J Infect Dis 202 Suppl 3, S333-338, doi: 10.1086/655967 (2010).
7. Clerici, M. et al. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS 16, 1731-1741 (2002).
8. Carrillo, J. et al. HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein. AIDS 27, 1375-1385, doi: 10.1097/QAD.0b013e32835fac08 (2013).
9. Murashev, B. V. et al. The high frequency of HIV type 1-specific cellular immune responses in seronegative individuals with parenteral and/or heterosexual HIV type 1 exposure. AIDS Res Hum Retroviruses 28, 1598-1605, doi: 10.1089/AID.2011.0335 (2012).
10. Erickson, A. L. et al. Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+ ) T-cell responses which can be defined to the epitope level. Clin Vaccine Immunol 15, 1745-1748, doi: 10.1128/CVI.00247-08 (2008).
11. Koning, F. A. et al. Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 175, 6117-6122 (2005).
12. Miss D. et al. IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J Immunol 178, 407-415 (2007).
13. Kim, C. J. et al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol 5, 670-680, doi: 10.1038/mi.2012.72 (2012).
14. Fernandes, S. M. et al. Enteric Mucosa Integrity in the Presence of a Preserved Innate Interleukin 22 Compartment in HIV Type 1-Treated Individuals. J Infect Dis 210, 630-640, doi: 10.1093/infdis/jiu126 (2014).
15. Chege, D. et al. Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya. PLoS One 7, e43670, doi: 10.1371/journal.pone.0043670 (2012).
16. McLaren, P. J. et al. HIVexposed seronegative commercial sex workers show a quiescent phenotype in the CD4+ T cell compartment and reduced expression of HIVdependent host factors. J Infect Dis 202 Suppl 3, S339-344, doi: 10.1086/655968 (2010).
17. Betts, M. R. et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107, 4781-4789, doi: 10.1182/blood-2005-12-4818 (2006).
18. Ferre, A. L. et al. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 113, 3978-3989, doi: 10.1182/blood-2008-10-182709 (2009).
19. Brandt, L. et al. HIV-1-infected individuals in antiretroviral therapy react specifically with polyfunctional T-cell responses to Gag p24. J Acquir Immune Defic Syndr 63, 418-427, doi: 10.1097/QAI.0b013e31828fa22b (2013).
20. Van Braeckel, E. et al. Polyfunctional CD4(+ ) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine. Vaccine 31, 3739-3746, doi: 10.1016/j.vaccine.2013.05.021 (2013).
21. Boaz, M. J., Waters, A., Murad, S., Easterbrook, P. J., Vyakarnam, A. Presence of HIV-1 Gag-specific IFN-gamma+ IL-2+ and CD28+ IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J Immunol 169, 6376-6385 (2002).
22. Bixler, S. L., Mattapallil, J. J. Loss and dysregulation of Th17 cells during HIV infection. Clin Dev Immunol 2013, 852418, doi: 10.1155/2013/852418 (2013).
23. Xu, H., Wang, X., Veazey, R. S. Th17 Cells Coordinate with Th22 Cells in Maintaining Homeostasis of Intestinal Tissues and both are Depleted in SIV-Infected Macaques. J AIDS Clin Res 5, doi: 10.4172/2155-6113.1000302 (2014).
24. Ciccone, E. J. et al. CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors. J Virol 85, 5880-5888, doi: 10.1128/JVI.02643-10 (2011).
25. Page, E. E. et al. Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection. J Acquir Immune Defic Syndr 67, 227-235, doi: 10.1097/QAI.0000000000000294 (2014).
26. Lima, J. F. et al. Distinct Natural Killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56dim and CD56bright cells and memory-like CD57+ NKG2C+ CD56dim cells. J Acquir Immune Defic Syndr, doi:10.1097/QAI.0000000000000350 (2014).
27. Pera, A. et al. CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals. PLoS One 9, e88538, doi: 10.1371/journal.pone.0088538 (2014).
28. Benito, J. M. et al. CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy. AIDS Res Hum Retroviruses 20, 227-233, doi: 10.1089/088922204773004950 (2004).
29. Hua, S. et al. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers. PLoS One 9, e101920, doi: 10.1371/journal.pone.0101920 (2014).
30. Baud, E. et al. Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 3, 35, doi: 10.1186/1742-4690-3-35 (2006).
31. Suy, A. et al. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation. J Infect Dis 196, 1191-1201, doi: 10.1086/521193 (2007).